Posts Tagged ‘otcbb’

Carbon Sciences, Inc. (CABN) – Penny Buzz Stock of the Day

Tuesday, June 8th, 2010

Shares of alternative energy solutions provider, Carbon Sciences, Inc. were up more than 70 percent in morning trading on Tuesday.

Carbon Sciences announced on Monday that it filed the first of a series of patent applications for its clean-tech CO2 based Gas to Liquids (GTL) fuel technology for transforming a combination of natural gas and carbon dioxide (CO2) directly into gasoline. This first patent application discloses the design and manufacturing of a novel chemical catalyst that converts methane gas and carbon dioxide gas (CO2) directly into gasoline. These greenhouse gases can be sourced from natural gas fields or human made coal-fired power plants, landfill gas, municipal waste, and algae.

[–quote–]

“This heralds a new era for Carbon Sciences and means that our plan for delivering a market-ready technology could be delivered as soon as next year,” said Byron Elton, CEO of Carbon Sciences in a statement. “The ongoing tragic events involving BP’s unchecked flow of oil into the Gulf of Mexico further underscores the urgent need to reduce and eliminate our addiction to petroleum, foreign and domestic. Carbon Sciences’ breakthrough technology takes us closer to a world without petroleum by essentially transforming pollution into energy.”

Shares were trading as high as $0.12 in morning trading on Tuesday, up 71 percent from Monday’s closing price of $0.07 per share.

Belltower Entertainment Corp. (BTOW) – Penny Buzz Stock of the Day

Monday, June 7th, 2010

Shares of Belltower Entertainment Corp. (OTCBB: BTOW) were up more than 30 percent today on heavy volume after the company announced its intent to begin producing direct response commercials.

Potential revenue sources for the company will include production fees from the commercials and back end profit participation in the products being marketed to the public through the television commercials the company produces.

[–quote–]

Last week, the company announced that it has attached director, Michael D. Olmos (Splinter), and Academy Award Winner Forest Whitaker to star in, and serve as the executive producer for Belltower Entertainment’s feature film entitled “Little Treasure,” which tells the story of an American, bi-racial couple. The film will be shot entirely on location in Shanghai. Belltower Entertainment Corp. used a portion of a $1 million credit facility to secure Whitaker and Olmos through William Morris Endeavour Agency (WME) where they are both repped.

Belltower will retain copyright ownership of the film, and will have majority control over production, financing and distribution.

Penny Buzz Stocks – LNG, SECI, UCHC

Friday, June 4th, 2010

Here are 3 penny stocks to add to your watch list today:

Cheniere Energy, Inc. (AMEX:LNG): Shares up after the company announced plans to export U.S. natural gas overseas from its Sabine Pass terminal in Louisiana in a strategy shift prompted by large increases in U.S. natural gas production.

Sector 10, Inc. (OTCBB: SECI): Up 30 percent on high volume after the company announced the upcoming release of the PLX-3D integration software package and its integrated components as an easy to use mobile application for the iPhone and iPad produced by Apple.

Uni Core Holdings Corp. (OTCBB: UCHC): Up 32 percent today on decent volume. Recent developments include a new research report from Skymark Research, and plans to close the acquisition of APT Paper Group, which includes FG Management Company Limited, Global Golden Group Investments Co., Ltd., Wise Link Management Ltd., Plan Star Development Limited, and Sure Strong Limited. Uni Core Holdings Corp. is an ‘incubator’ of mid- to large-size companies in China.

Penny Buzz Stocks to Watch – ENMD, IMUC, OOAG

Wednesday, June 2nd, 2010

Here are a few penny stocks on our radar today and why:

Entremed, Inc. (Nasdaq: ENMD): announced the publication of preclinical results for its clinical-stage Aurora A/angiogenic kinase inhibitor, ENMD-2076, in human colorectal cancer xenograft models. ENMD-2076 demonstrated robust antitumor activity against murine xenograft models of human colorectal cancer (CRC) established from both cell lines and primary human samples.

ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC): Announced positive results from a Phase I study of the company’s immune-based cancer therapy, ICT-107.

OMDA Oil and Gas, Inc. (Pink Sheets: OOAG): Announced a reduction of 12,000,000 common shares which is 5 percent of the total outstanding share count. Upon the completion of all of the announced share retirements the new outstanding share count will stand at 172,610,100. In total OMDA Oil and Gas, Inc. will have reduced its outstanding share total nearly 30% from the original 242,610,100. Upon completion of all pending share cancellations OMDA’s insiders will collectively hold less than 10% of the common vote.

Sign up for our Buzz Stock alerts via e-mail and get our Buzz Stocks first!

Vasomedical, Inc. (VASO) – Penny Stock of the Day

Monday, May 24th, 2010

Shares of Vasomedical, Inc. (OTCBB: VASO) were up as much as 86 percent on Monday after the company announced that its subsidiary was appointed the exclusive representative for select GE Healthcare Diagnostic Imaging products to specific market segments in the 48 contiguous states of the United States and District of Columbia received signed a sales representative agreement. GE Healthcare is the healthcare business unit of GE (NYSE: GE – News). The Company has already received financial commitments for up to $5 million to fund this project.

[–quote–]

“This representation agreement is an example of Vasomedical’s strategy to expand its operations into new areas of potential growth in healthcare,” stated Abraham E. Cohen, Chairman of the Board of Vasomedical, Inc. in a statement.

The agreement is for an initial term of three years commencing July 1, 2010, subject to extension and also subject to earlier termination under certain circumstances.

Vasomedical, Inc. is primarily engaged in designing, manufacturing, marketing and supporting EECP(R) external counterpulsation systems based on the Company’s proprietary technology. Offered exclusively by Vasomedical, EECP therapy is a safe, non-invasive, outpatient treatment option for patients suffering from ischemic heart diseases such as angina and heart failure

In early April, the company announced that it received clearance from the U.S. Food and Drug Administration to market its Vasomedical-BIOX™ Model 2301 Combined ECG Holter and Ambulatory Blood Pressure Monitoring Recorder and Software Analysis System.

“These are the first in a line of Vasomedical-BIOX™ ECG Holter and Ambulatory Blood Pressure Monitoring Systems that Vasomedical intends to bring to the marketplace,” said Dr. Jun Ma, President and CEO of Vasomedical, Inc.

Shares of Vasomedical are up more than 300 percent over the past 12 months.